Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
62 (26%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-METFORMIN ER | 1000MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-07-23 | 2021-10-05 | 142982 |
| APO-METFORMIN ER | 1000MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-10-07 | 2021-12-06 | 146795 |
| APO-METFORMIN ER | 1000MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-12-09 | 2022-01-24 | 150839 |
| APO-METFORMIN ER | 1000MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-02-09 | 2023-02-23 | 184100 |
| APO-METFORMIN ER | 1000MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-03-09 | 2023-04-06 | 186575 |
| APO-METFORMIN ER | 1000MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-04-14 | 2024-02-02 | 189647 |
| APO-METFORMIN ER | 1000MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-02-24 | 2019-04-15 | 76726 |
| APO-METFORMIN ER | 1000MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-05-08 | 2019-06-24 | 83504 |
| APO-METFORMIN ER | 1000MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-07-03 | 2019-08-03 | 88336 |
| APO-METFORMIN ER | 1000MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-08-21 | 2019-08-30 | 92026 |
| APO-METHIMAZOLE | 5MG | TABLET | Actual shortage | 2017-08-14 | 2017-10-05 | 19320 |
| APO-METHOTREXATE | 2.5MG | TABLET | Resolved | 2018-07-09 | 2021-07-23 | 54770 |
| APO-METHOTREXATE | 2.5MG | TABLET | Actual shortage | 2025-05-01 | 2025-05-01 | 256312 |
| APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2022-03-18 | 2022-04-18 | 156993 |
| APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2022-05-20 | 2022-06-22 | 161029 |
| APO-METHYLPHENIDATE | 20MG | TABLET | Resolved | 2017-11-22 | 2018-01-25 | 30084 |
| APO-METHYLPHENIDATE | 5MG | TABLET | Resolved | 2018-01-18 | 2018-03-13 | 36446 |
| APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2017-03-11 | 2017-04-04 | 592 |
| APO-METHYLPHENIDATE | 10MG | TABLET | Resolved | 2024-06-20 | 2024-07-19 | 231036 |
| APO-METHYLPHENIDATE | 20MG | TABLET | Resolved | 2021-04-05 | 2021-05-17 | 136799 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
| APO-HYDROMORPHONE CR | 3MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110956 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |